Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over ...
F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Gazyva/Gazyvaro for lupus nephritis
Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...
Here at Ars, we have been writing about rumors of a portable Xbox for literal decades now. With the ROG Xbox Ally, Microsoft ...
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 30 abstracts ...
GlaxoSmithKline and partner Vir Biotechnology will expand their trial of an experimental antibody to treat COVID-19 after initial use by a group of volunteers did not raise any safety concerns.
Rail Operations Group's Class 93 fleet has made its revenue-earning debut, taking a pair of '175' diesel multiple units from ...
Our team of deal hunters has found bargains on big-ticket items that you can jump on during October’s Amazon Prime Days.
Camden County Presiding Commissioner Skelton had all felony charges dropped and pleaded guilty to a misdemeanor charge of ...
The Week 7 high school rankings from Dave Campbell’s Texas Football magazine and TexasFootball.com, distributed by The Associated Press: CLASS 6A Rank School (Record) Week 6 Prv rank ...
The Renew Jordan Creek project has reached a major milestone, with its daylighting initiative halfway completed in downtown Springfield. The daylighting project aims to unearth ...
Craig Counsell has seen the Milwaukee Brewers-Chicago Cubs rivalry from just about every perspective. He grew up in the Milwaukee area as the son of former Brewers director of community affairs ...
Novartis shines with oncology growth, strong buybacks, and a $1.4B heart drug acquisition, defying headwinds like Entresto generics. Read why NVS stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results